Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000174
-
Shares outstanding
-
55,833,616
-
Total 13F shares
-
7,118,656
-
Share change
-
-2,959,887
-
Total reported value
-
$8,400,371
-
Price per share
-
$1.18
-
Number of holders
-
14
-
Value change
-
-$3,060,514
-
Number of buys
-
6
-
Number of sells
-
8
Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB) as of Q4 2023
As of 31 Dec 2023,
Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,118,656 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., BML Capital Management, LLC, BlackRock Inc., UBS OCONNOR LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, RHUMBLINE ADVISERS, XTX Topco Ltd, TWO SIGMA SECURITIES, LLC, and TWO SIGMA INVESTMENTS, LP.
This page lists
14
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.